Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-enteropancreatic Neuroendocrine Tumor”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Not applicableLooking for participantsNCT04090034
What this trial is testing

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsGastroenteropancreatic Neuroendocrine Tumor
Methodist Health System 50
Not applicableLooking for participantsNCT06356467
What this trial is testing

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

Who this might be right for
Neuroendocrine TumorsGEP-NET
IRCCS San Raffaele 450
Not applicableLooking for participantsNCT07302100
What this trial is testing

Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
University Hospital, Strasbourg, France 100
Early research (Phase 1)Active Not RecruitingNCT03833700
What this trial is testing

E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Who this might be right for
Solid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors
Eisai Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT04296149
What this trial is testing

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

Who this might be right for
Neuroendocrine Tumors
European Institute of Oncology 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Not applicableStudy completedNCT02948946
What this trial is testing

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm
H. Lee Moffitt Cancer Center and Research Institute 105
Post-approval studies (Phase 4)WithdrawnNCT02779257
What this trial is testing

Pasireotide Treatment for Neuroendocrine Tumor

Who this might be right for
Gastro-enteropancreatic Neuroendocrine Tumor
University of Maryland, Baltimore
Not applicableLooking for participantsNCT06155318
What this trial is testing

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
IRCCS San Raffaele 300
Very early researchActive Not RecruitingNCT04993261
What this trial is testing

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Who this might be right for
Carcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more
M.D. Anderson Cancer Center 71
Large-scale testing (Phase 3)Active Not RecruitingNCT05050942
What this trial is testing

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

Who this might be right for
Gastro-enteropancreatic Neuroendocrine Tumor
Camurus AB 332
Large-scale testing (Phase 3)Active Not RecruitingNCT03049189
What this trial is testing

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 324
Not applicableStudy completedNCT04946305
What this trial is testing

A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea

Who this might be right for
Somatostatin Receptor-positive GEP-NET
Novartis Pharmaceuticals 89
Not applicableLooking for participantsNCT07319416
What this trial is testing

DCEUS to Assess Treatment Response to PRRT in GEP-NET

Who this might be right for
NETRadionucleide TherapyContrast Enhanced Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Testing effectiveness (Phase 2)WithdrawnNCT04614766
What this trial is testing

A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorNeuroendocrine Tumors
David Bushnell
Testing effectiveness (Phase 2)Study completedNCT00454363
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 52
Very early researchLooking for participantsNCT05359146
What this trial is testing

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
University Hospital, Basel, Switzerland 16
Early research (Phase 1)Looking for participantsNCT06441331
What this trial is testing

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Who this might be right for
Somatostatin Receptor PositiveNETsLymphoma+5 more
ITM Solucin GmbH 20
Testing effectiveness (Phase 2)Study completedNCT03043664
What this trial is testing

Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Duke University 22
Not applicableLooking for participantsNCT04949282
What this trial is testing

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Who this might be right for
Neuroendocrine TumorsIntestinal NeoplasmsPancreatic Neoplasms+15 more
Sociedad Española de Medicina Nuclear e Imagen Molecular 5,000
Load More Results